S&P 500 Healthcare Sector SEC Filings — January 28, 2026

29-01-2026

Encision Inc filed a Form 8-K on January 29, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts were disclosed. Filing size was 207 KB, but no quantitative financial data, positive or negative metrics, or comparisons were provided.

29-01-2026

NewtekOne, Inc. filed an 8-K on 2026-01-29 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are provided in the available information. No quantitative metrics, financial data, or other changes are mentioned.

29-01-2026

Juniata Valley Financial Corp filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits attached.

29-01-2026

FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC. filed an 8-K on January 29, 2026 (AccNo: 0001174947-26-000104), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing furnishing earnings-related information, but no specific revenue, earnings, balance sheet details, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing description. No positive, negative, or flat performance indicators are available.

• ·File size: 339 KB

29-01-2026

Matthews International Corp filed an 8-K on January 29, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary.

29-01-2026

PEOPLES FINANCIAL CORP /MS/ filed a Form 8-K on January 29, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other numerical data are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

• ·Filing Accession Number: 0001104659-26-007847
• ·Filing size: 324 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Capitol Federal Financial, Inc. filed a Form 8-K on January 29, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a recent shareholder meeting. The filing also includes Item 7.01 for Regulation FD Disclosure of material information and Item 9.01 for financial statements and exhibits. No specific vote outcomes, financial metrics, transaction details, or quantitative data are disclosed.

29-01-2026

Riverview Bancorp Inc filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing information. No positive, negative, or flat performance indicators were detailed.

• ·Filed: 2026-01-29
• ·AccNo: 0000939057-26-000026
• ·File Size: 2 MB
• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: not specified

29-01-2026

MUNCY COLUMBIA FINANCIAL Corp filed an 8-K on January 29, 2026 (AccNo: 0001174947-26-000109, Size: 359 KB), disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific terms, financial impacts, or quantitative details about the agreement are provided in the filing summary. This is a mandatory multi-item disclosure without directional metrics.

• ·AccNo: 0001174947-26-000109
• ·Filing Size: 359 KB

29-01-2026

TFS Financial CORP filed an 8-K on January 29, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics are disclosed in the provided information. This appears to be a standard voluntary earnings release with no detailed performance data available.

29-01-2026

Enterprise Financial Services Corp filed an 8-K on January 29, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a voluntary disclosure likely disseminating previously selective material information via attached exhibits. No financial metrics, transactions, or performance data are explicitly stated.

• ·AccNo: 0001025835-26-000026
• ·Filing date: 2026-01-29

29-01-2026

Thermo Fisher Scientific Inc. filed an 8-K on 2026-01-29 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing information. This is an informational earnings-related disclosure without detailed data.

29-01-2026

Velocity Financial, Inc. filed an 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative performance metrics.

29-01-2026

News Corp filed an 8-K on January 29, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are provided. This filing contains no quantitative metrics, positive or negative performance indicators, or period-over-period comparisons.

29-01-2026

Revelation Biosciences, Inc. filed a multi-item Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 3.03 material modifications to rights of security holders, with exhibits under Item 9.01. These disclosures signal a strategic transaction potentially positive for operations or funding, however, the equity sales and rights modifications raise dilution risks for existing shareholders. Specific transaction details, dollar values, share counts, and financial impacts are NOT_DISCLOSED.

29-01-2026

New ERA Energy & Digital, Inc. filed an 8-K on January 29, 2026, reporting under Item 8.01 (Other Events), a voluntary disclosure category for material information not covered elsewhere, and Item 9.01 (Financial Statements and Exhibits), which attaches supporting documents. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary. This multi-item filing provides limited transparency without quantified impacts, positive or negative.

29-01-2026

Ameriprise Financial Inc filed an 8-K on January 29, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no detailed performance data available.

29-01-2026

BREAD FINANCIAL HOLDINGS, INC. filed a Form 8-K on 2026-01-29 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing summary. No positive or negative performance details, period-over-period comparisons, or strategic updates are explicitly stated.

29-01-2026

Coastal Financial Corp filed an 8-K on 2026-01-29 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

29-01-2026

LPL Financial Holdings Inc. filed an 8-K on January 29, 2026 (AccNo: 0001628280-26-004112, Size: 1 MB), reporting results of operations and financial condition under Item 2.02. Financial statements and exhibits are included under Item 9.01. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed.

29-01-2026

Virtu Financial, Inc. filed an 8-K on January 29, 2026 (AccNo: 0001592386-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

29-01-2026

Mind Medicine (MindMed) Inc. filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-028186), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed. Sector information is not specified.

29-01-2026

International Paper Co /New/ filed an 8-K on 2026-01-29 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing description. This is a standard mandatory disclosure for financial results with no detailed quantitative data available.

29-01-2026

OneWater Marine Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001772921-26-000015), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure for a US equity market company in an unspecified sector. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other performance data are disclosed in the provided filing information.

29-01-2026

Bankwell Financial Group, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001505732-26-000001, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics in the available summary. No positive or negative performance indicators, comparisons, or guidance are detailed.

29-01-2026

Arrow Financial Corp filed an 8-K on January 29, 2026, triggering Item 5.02 for departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 2.02 for results of operations and financial condition, Item 7.01 for Regulation FD disclosure, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. Specific details on the officer change, including key position affected, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

29-01-2026

Univest Financial Corp filed an 8-K on January 29, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons are disclosed in the provided filing information.

29-01-2026

HANMI FINANCIAL CORP filed an 8-K on January 29, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or content of the exhibits are disclosed in the filing summary. This appears to be a multi-item informational filing with attached materials, but core event and financial impacts are NOT_DISCLOSED.

29-01-2026

Civista Bancshares, Inc. filed a Form 8-K on January 29, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing description. This is a standard voluntary earnings release filing with no detailed performance data available.

29-01-2026

B. Riley Financial, Inc. filed a Form 8-K on January 29, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed financial impacts.

29-01-2026

FINANCIAL INSTITUTIONS INC filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but all performance data remains NOT_DISCLOSED.

29-01-2026

FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but no specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing details. No positive, negative, or flat performance indicators are available.

29-01-2026

BayFirst Financial Corp. filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, with no specific revenue, earnings, or other metrics detailed in the provided filing information. No positive or negative performance indicators are disclosed.

29-01-2026

InPoint Commercial Real Estate Income, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029384, Size: 180 KB), reporting solely under Item 8.01 Other Events. No specific details of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. Sector is not specified.

29-01-2026

OceanFirst Financial Corp filed an 8-K on January 29, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses material nonpublic information voluntarily to comply with Regulation FD, with exhibits attached, but no specific financial metrics, transactions, or performance data are detailed. No positive or negative metrics, period-over-period changes, or directional impacts are mentioned.

29-01-2026

Axos Financial, Inc. filed an 8-K on 2026-01-29 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary earnings release filing with attached materials, but no specific revenue, earnings, margins, balance sheet details, period-over-period comparisons, or guidance were explicitly stated in the provided filing metadata. No positive or negative metrics available for balanced assessment.

29-01-2026

CITIZENS FINANCIAL SERVICES INC filed a Form 8-K on January 29, 2026 (AccNo: 0000739421-26-000010), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard financial results announcement with no specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics explicitly stated in the provided filing details. No positive or negative performance indicators, guidance, or scheduled events are mentioned.

29-01-2026

Stryker Corp filed an 8-K on January 29, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing information. All quantitative financial data is NOT_DISCLOSED.

• ·Filing Accession Number: 0000310764-26-000006
• ·File size: 1 MB
• ·Event Type: Financial Results

29-01-2026

MEDALLION FINANCIAL CORP filed an 8-K on January 29, 2026, reporting under Item 7.01 for Regulation FD Disclosure, which involves voluntary release of material non-public information to ensure broad dissemination. Item 9.01 includes Financial Statements and Exhibits, potentially attaching supporting documents. No specific financial metrics, transactions, positive or negative changes, or other quantitative details are disclosed in the filing summary.

29-01-2026

FIRST FINANCIAL BANKSHARES INC filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided filing summary.

29-01-2026

PennyMac Financial Services, Inc. filed an 8-K on January 29, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned in the provided filing details. This represents a standard earnings-related disclosure without quantified financial impacts.

29-01-2026

Harvard Bioscience Inc filed an 8-K on January 29, 2026, reporting under Item 2.05 costs associated with exit or disposal activities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative details such as dollar amounts, cost savings, or specific impacts are disclosed in the provided filing summary. This multi-item filing signals a material restructuring or disposal event alongside voluntary information disclosure.

29-01-2026

Peapack Gladstone Financial Corp filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a multi-item filing focused on financial results disclosure.

29-01-2026

CITIZENS FINANCIAL GROUP INC/RI filed an 8-K on January 29, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events, transactions, financial impacts, or exhibits are NOT_DISCLOSED. No quantitative metrics, comparisons, or directional changes (positive, negative, or flat) are provided in the filing summary.

• ·Filing Accession Number: 0001193125-26-029534
• ·File Size: 595 KB

29-01-2026

CANADIAN PACIFIC KANSAS CITY LTD filed an 8-K on 2026-01-29 under Items 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating an officer change event. Specific details on the affected position, individual name, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or period-over-period comparisons are mentioned.

29-01-2026

Primis Financial Corp. filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-008048), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results but contains no specific revenue, earnings, or other metrics explicitly stated. No positive or negative performance details, guidance, or comparisons are disclosed.

29-01-2026

Dare Bioscience, Inc. filed a Form 8-K on January 29, 2026, reporting under Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing indicates governance changes and potential capital raising activities without specified positive or negative metrics.

29-01-2026

Rallybio Corp filed an 8-K on January 29, 2026, disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, and submission of matters to a vote of security holders under Item 5.07, with financial statements and exhibits attached under Item 9.01. No specific details on the nature of amendments, vote outcomes, or any financial metrics were provided in the filing summary. This is a multi-item informational filing with no quantified positive or negative impacts disclosed.

29-01-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on 2026-01-29 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative transaction details, financial metrics, or impacts are provided in the filing summary.